MEASURING, PREDICTING, AND
ENGINEERING PROTEIN INTERACTIONSat Scale
A-Alpha Bio harnesses synthetic biology and machine learning to precisely engineer high-impact medicines.
By measuring millions of protein-protein interactions simultaneously, we accelerate innovation and improve human health.
Billionprotein-protein interactions measured to date
Fueling Discoveries with High-Throughput Data and Machine Learning
Protein-protein interactions govern all of biology and are crucial for understanding and combating disease.
However, a lack of abundant and high-quality protein-protein interaction data limits our understanding and ability to treat cancers, infectious diseases, neurological diseases, and more.
A-Alpha Bio generates the high-throughput data needed to discover rare and effective antibodies, identify degradable neo-substrates, engineer protein interfaces, and fuel predictive machine learning models to further accelerate the discovery and optimization of high-impact drugs.
AlphaSeq + AlphaBind
Measuring and Predicting Protein-Protein Interactions at an Unprecedented Scale
AlphaSeq is the leading platform for quantitative and multiplexed characterization of protein-protein interactions. Leveraging synthetic biology, we have generated the largest repository of high-quality protein interaction data in the world.
AlphaBind harnesses our accumulated data to train machine learning models capable of predicting binding from protein sequence. Computational designs are measured experimentally for model validation and refinement through rapid iterations.
We partner with leading companies and institutions who share our mission to improve human health.
